Triumeq
- Product NDC
- 49702-231
- 11-digit product format
- 497020231
- Labeler code
- 49702
- Product ID
- 49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- abacavir sulfate, dolutegravir sodium, lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ViiV Healthcare Company
- Application
- NDA205551
- Marketing category
- NDA
- Marketing start
- 2014-08-22
- Substance
- ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
- Active strength
- 600; 50; 300 mg/1; mg/1; mg/1
- Pharmacologic classes
- Cytochrome P450 1A1 Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triumeq
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ABACAVIR SULFATE | 600 mg/1 |
| DOLUTEGRAVIR SODIUM | 50 mg/1 |
| LAMIVUDINE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J220T4J9Q2, 1Q1V9V5WYQ, 2T8Q726O95 |
| Rxcui | 1546888, 1546894, 2598348, 2598352 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 49702-231-13 | Triumeq | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 30 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| DOLUTEGRAVIR SODIUM | ACTIVE INGREDIENT | 1Q1V9V5WYQ | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| ABACAVIR | ACTIVE MOIETY | WR2TIP26VS | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| DOLUTEGRAVIR | ACTIVE MOIETY | DKO1W9H7M1 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| SODIUM STARCH GLYCOLATE TYPE A CORN | INACTIVE INGREDIENT | AG9B65PV6B | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 49702-231 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) KIT [VIIV HEALTHCARE COMPANY] | 27 | Current NDC, Legacy NDC, 1 package rows | 20240711_2997739a-aa91-42aa-a206-a70e2db7b84f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49702-231-13 | 49702023113 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13) | 2014-08-22 | 0000-00-00 | No | No | Current |